Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Accepted on 08 Apr 2025

Prevalence, risk characteristics, and prediction of low-dose edoxaban treatment in hospitalized patients: a multicenter, observational cohort study

in Drugs Outcomes Research and Policies

Shujuan Zhao
Hengfen Dai
Jiaxin Chen
Ming Ni
Wenxing Peng
Xiaoyu Li
Fen Li
Boya Chen
Haixia Cai
Yinping Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1427634

Original Research

Published on 08 Apr 2025

Potential inappropriate medications and drug–drug interactions in adverse drug reactions in the elderly: a retrospective study in a pharmacovigilance database

in Drugs Outcomes Research and Policies

Huaqiao Jiang
Yanhua Lin
Weifang Ren
Lina Lu
Xiaofang Tan
Xiaoqun Lv
Ning Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1546012

341 views

Original Research

Published on 08 Apr 2025

Assessment of competencies of clinical research professionals and proposals to improve clinical research in Portugal

in Drugs Outcomes Research and Policies

Mónica Bogas
Joana Antas
Cátia Magalhães
Mafalda Revige
Liliana Guerra
Cheila Ribeiro
Rita Cunha Eça
Filipa Nunes
Ana Lopes
Luís Costa

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1578955

378 views

Systematic Review

Accepted on 07 Apr 2025

Cost-effectiveness analysis of Amivantamab plus Lazertinib, Lazertinib versus Osimertinib in NSCLC with EGFR

in Drugs Outcomes Research and Policies

Yueyun Li
Liu Yuhang
Hui Zhang
Haonan Li
Hong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1527614

Original Research

Published on 07 Apr 2025

Drug-therapy-related problems and pharmacist interventions in the medical ward in northeast Ethiopia: focus on types, acceptability, and impacts

in Drugs Outcomes Research and Policies

Bedilu Linger Endalifer
Yared Dergu Ayta
Abate Wondesen Tsigie
Yehualashet Teshome Wondmkun
Mekuanint Terefe Kassa
Gedefaw Getnet Amare
Yenesew Wudu Ejigu
Manaye Tamrie Derseh
Abyou Seyfu Ambaye

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558864

291 views

Original Research

Published on 07 Apr 2025

Economic costs and medications for diabetes in older patients in Beijing, China: electronic insurance data analysis

in Drugs Outcomes Research and Policies

Yanhua Ma
Yan Zhao
Ran Wei
Jingtao Qiao
Jingyi Luo
Lina Zhang
Jie Zhang
Mingqun Deng
Yang Yu
Weihao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1549244

238 views

Original Research

Published on 03 Apr 2025

Anticoagulation quality with warfarin therapy, and associated factors among adult outpatients at public hospitals in nekemte town, western Ethiopia: a retrospective study

in Drugs Outcomes Research and Policies

Firafan Shuma Teka
Ayana Tadesse Korsa
Habte Gebeyehu Bayisa
Dechasa Befikadu W/Senbat
Refisa Shifera Beyene
Dinka Dugassa Iticha
Birbirsa Sefera Senbeta

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1544957

364 views

Original Research

Published on 03 Apr 2025

Argatroban in patients with acute ischemic stroke with early neurological deterioration: a cost-effectiveness analysis from the perspective of Chinese healthcare system

in Drugs Outcomes Research and Policies

Yu Xie
Liping Hu
Ping Xu
Xianbin Guo
Junxiu Cai
Min Pan
Jie Tang
Qingtao Gong
Rong Su
Yake Lou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1470373

241 views

Original Research

Published on 02 Apr 2025

Development and validation of a Chinese insulin medication literacy scale for patients with diabetes mellitus

in Drugs Outcomes Research and Policies

Fangying Si
Tao Feng
Xiangfen Shi
Sufang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1477050

475 views

Original Research

Published on 02 Apr 2025

Overall compilation of adverse effects of non-steroidal anti-inflammatory drugs: a hypothesis-free systematic investigation using a nationwide cohort study

in Drugs Outcomes Research and Policies

Hyein Han
Du Hyun Ro
Hyuk-Soo Han
Sungho Won

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1539328

540 views

Original Research

Published on 01 Apr 2025

Assessment of Gliflozins prescribing pattern in a United Arab Emirates tertiary-level care hospital

in Drugs Outcomes Research and Policies

Wessa Shenouda
Dixon Thomas
Omar Nabi
Seeba Zachariah

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529528

661 views

Original Research

Published on 01 Apr 2025

Irisin protects against cerebral ischemia reperfusion injury in a SIRT3-dependent manner

in Drugs Outcomes Research and Policies

Yushuang Cong
Ruichun Guo
Chenglong Li
Qi Li
Sihua Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558457

342 views

Original Research

Published on 31 Mar 2025

Specific drugs for rare diseases in a province of eastern China under catalog management: from 2021 to 2023

in Drugs Outcomes Research and Policies

Ruifang Nie
Zhen Zhao
Yahui Zhang
Bo Xu
Wen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1476910

435 views

Original Research

Published on 31 Mar 2025

The clinical assessment of studies on orphan drugs in relation to the EMA’s authorization marketing decisions in Europe

in Drugs Outcomes Research and Policies

Szczepan Jakubowski
Krzysztof Piotr Malinowski
Paweł Kawalec

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558987

393 views

Systematic Review

Published on 28 Mar 2025

Factors influencing the cost-effectiveness of novel oral anticoagulants compared to vitamin K antagonists in patients with atrial fibrillation: a systematic review

in Drugs Outcomes Research and Policies

Yan Li
Xintian Wang
Aixia Ma
Pingyu Chen
Hongchao Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1441754

481 views

Original Research

Published on 26 Mar 2025

An analysis of the clinical application of paliperidone palmitate injection based on real-world

in Drugs Outcomes Research and Policies

Ruixue Liu
Chunxiao Liu
Di Hu
Longkun Wang
Dianwei Feng
Tongxin Guo
Ying Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1501701

665 views